Article info

Download PDFPDF
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020

Authors

  • Olivier Lortholary Paris University, Necker Pasteur Center for Infectious Diseases and Tropical Medicine, IHU Imagine, Necker Enfants malades University Hospital, APHP, Paris, France Institut Pasteur, National Reference Center for Invasive Mycoses and Antifungals, Molecular Mycology Unit, CNRS UMR 2000, Paris, France PubMed articlesGoogle scholar articles
  • Mario Fernandez-Ruiz Unit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), School of Medicine, Universidad Complutense, Madrid, Spain Spanish Network for Research in Infectious Diseases (REIPI RD16/0016), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • John W Baddley University of Maryland School of Medicine, Division of Infectious Diseases, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Oriol Manuel Infectious Diseases Service and Transplantation Center, University Hospital and University of Lausanne, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Xavier Mariette Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux universitaires Paris-Sud – Hôpital Bicêtre, Le Kremlin Bicêtre, France Université Paris-Sud, Center for Immunology of Viral Infections and Auto-immune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Kevin L Winthrop Oregon Health Sciences University, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Olivier Lortholary, Paris University, 75015 Paris, France; olivier.lortholary{at}aphp.fr
View Full Text

Citation

Lortholary O, Fernandez-Ruiz M, Baddley JW, et al
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020

Publication history

  • Received February 2, 2020
  • Revised May 28, 2020
  • Accepted June 16, 2020
  • First published September 22, 2020.
Online issue publication 
November 13, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.